Back
Freeport-McMoRan Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
47
FCX
Freeport-McMoRan
Last Price:
$42.78
Seasonality Move:
-0.68%
Sell
43
ASND
Ascendis Pharma AS
Last Price:
$173.38
Seasonality Move:
10.84%
Sell
47
Freeport-McMoRan (FCX)
is a Sell
Is Freeport-McMoRan a Buy, Sell or Hold?
-
The current Freeport-McMoRan [FCX] share price is $41.48. The Score for FCX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
FCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $173.06. The Score for ASND is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FCX Stock Price Chart
What is Freeport-McMoRan's stock price today?
-
The Freeport-McMoRan share price today is $41.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing selling pressure, which indicates risk of future bearish movement.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $173.06The current trend is moderately bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
FCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.06 | Buy |
Relative Strength Index (14 RSI): | 65.09 | Buy |
Chaikin Money Flow: | -8413086 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.64 - 40.1) | Buy |
Bollinger Bands (100): | (34.99 - 40.17) | Buy |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4 | Buy |
Relative Strength Index (14 RSI): | 59.68 | Buy |
Chaikin Money Flow: | -322012 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (156.27 - 170.53) | Buy |
Bollinger Bands (100): | (135.82 - 165.94) | Buy |
FCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.1 | Buy |
20-day SMA: | 39.22 | Buy |
50-day SMA: | 36.85 | Buy |
200-day SMA: | 40.9 | Buy |
8-day EMA: | 40.41 | Buy |
20-day EMA: | 39.27 | Buy |
50-day EMA: | 38.16 | Buy |
200-day EMA: | 39.99 | Buy |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 170.01 | Buy |
20-day SMA: | 162.95 | Buy |
50-day SMA: | 159.29 | Buy |
200-day SMA: | 142.09 | Buy |
8-day EMA: | 170.8 | Buy |
20-day EMA: | 165.97 | Buy |
50-day EMA: | 160.47 | Buy |
200-day EMA: | 145.87 | Buy |
Freeport-McMoRan Earnings Growth & FCX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.07 per share, an increase this year of $0.20 per share, and an increase next year of $0.54 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.60 per share, an increase this year of $2.04 per share, and an increase next year of $7.41 per share.
Freeport-McMoRan Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |